Khan M, Perwez S, Gaddam R, Aiswarya R, Abrar Basha M, Malas A
Neuropsychiatr Dis Treat. 2024; 20:137-148.
PMID: 38282834
PMC: 10813253.
DOI: 10.2147/NDT.S436975.
Villalba S, Gonzalez B, Junge S, Bernardi A, Gonzalez J, Fagundez C
Int J Mol Sci. 2024; 25(2).
PMID: 38255760
PMC: 10815577.
DOI: 10.3390/ijms25020687.
Larson N, Tavernier R, Berge J, Barr-Anderson D, Neumark-Sztainer D
Emerg Adulthood. 2023; 11(3):779-796.
PMID: 37832141
PMC: 10064195.
DOI: 10.1177/21676968231166034.
Park H, Forthman K, Kuplicki R, Victor T, Yeh H, Thompson W
Psychiatry Res Neuroimaging. 2023; 335:111716.
PMID: 37717543
PMC: 10841151.
DOI: 10.1016/j.pscychresns.2023.111716.
Minoretti P, Saez A, Martin A, Liano Riera M, Gomez Serrano M, Emanuele E
Cureus. 2023; 15(7):e41616.
PMID: 37565100
PMC: 10410288.
DOI: 10.7759/cureus.41616.
Intersectionality in Alzheimer's Disease: The Role of Female Sex and Black American Race in the Development and Prevalence of Alzheimer's Disease.
Misiura M, Butts B, Hammerschlag B, Munkombwe C, Bird A, Fyffe M
Neurotherapeutics. 2023; 20(4):1019-1036.
PMID: 37490246
PMC: 10457280.
DOI: 10.1007/s13311-023-01408-x.
Psilocybin's effects on cognition and creativity: A scoping review.
Bonnieux J, VanderZwaag B, Premji Z, Garcia-Romeu A, Garcia-Barrera M
J Psychopharmacol. 2023; 37(7):635-648.
PMID: 37395359
PMC: 10350723.
DOI: 10.1177/02698811231179801.
Differences in Selective Attention and Inhibitory Control in Patients with Major Depressive Disorder and Healthy Controls Who Do Not Engage in Sufficient Physical Activity.
Gerber M, Cody R, Beck J, Brand S, Donath L, Eckert A
J Clin Med. 2023; 12(10).
PMID: 37240475
PMC: 10218814.
DOI: 10.3390/jcm12103370.
The relationship between theory of mind and executive functions in major depressive disorders: A review.
Pagnoni I, Gobbi E, Alaimo C, Campana E, Rossi R, Manenti R
Front Psychiatry. 2022; 13:980392.
PMID: 36051550
PMC: 9424552.
DOI: 10.3389/fpsyt.2022.980392.
Neurocognitive Impairment in Severe Mental Illness. Comparative study with Spanish Speaking Patients.
De la Torre G, Doval S, Lopez-Sanz D, Garcia-Sedeno M, Ramallo M, Bernal M
Brain Sci. 2021; 11(3).
PMID: 33808661
PMC: 8003381.
DOI: 10.3390/brainsci11030389.
Comprehensive Neuropsychiatric and Cognitive Characterization of Former Professional Football Players: Implications for Neurorehabilitation.
Terpstra A, Vasquez B, Colella B, Tartaglia M, Tator C, Mikulis D
Front Neurol. 2019; 10:712.
PMID: 31447753
PMC: 6696977.
DOI: 10.3389/fneur.2019.00712.
Personally salient, emotionally negative task contexts provoke goal neglect in depression.
Werner-Seidler A, Dahm T, Golden A, Manly T, Dalgleish T
Psychol Med. 2019; 50(5):874-880.
PMID: 31057139
PMC: 7168650.
DOI: 10.1017/S0033291719000886.
Depression: A cognitive perspective.
LeMoult J, Gotlib I
Clin Psychol Rev. 2018; 69:51-66.
PMID: 29961601
PMC: 11884012.
DOI: 10.1016/j.cpr.2018.06.008.
Cognitive Remediation and Bias Modification Strategies in Mood and Anxiety Disorders.
Gold A, Montana R, Sylvia L, Nierenberg A, Deckersbach T
Curr Behav Neurosci Rep. 2016; 3(4):340-349.
PMID: 27917364
PMC: 5127202.
DOI: 10.1007/s40473-016-0090-5.
Factors influencing community case management and care hours for clients with traumatic brain injury living in the UK.
Clark-Wilson J, Giles G, Seymour S, Tasker R, Baxter D, Holloway M
Brain Inj. 2016; 30(7):872-82.
PMID: 27058173
PMC: 4926787.
DOI: 10.3109/02699052.2016.1146799.
Audiovisual emotional processing and neurocognitive functioning in patients with depression.
Doose-Grunefeld S, Eickhoff S, Muller V
Front Integr Neurosci. 2015; 9:3.
PMID: 25688188
PMC: 4311605.
DOI: 10.3389/fnint.2015.00003.
Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder.
Madhoo M, Keefe R, Roth R, Sambunaris A, Wu J, Trivedi M
Neuropsychopharmacology. 2013; 39(6):1388-98.
PMID: 24309905
PMC: 3988542.
DOI: 10.1038/npp.2013.334.
Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review.
Snyder H
Psychol Bull. 2012; 139(1):81-132.
PMID: 22642228
PMC: 3436964.
DOI: 10.1037/a0028727.
Executive function deficits in children with attention-deficit/hyperactivity disorder and improvement with lisdexamfetamine dimesylate in an open-label study.
Turgay A, Ginsberg L, Sarkis E, Jain R, Adeyi B, Gao J
J Child Adolesc Psychopharmacol. 2010; 20(6):503-11.
PMID: 21186969
PMC: 3005278.
DOI: 10.1089/cap.2009.0110.
Toward the Study of Trans-Disease Processes: A Novel Approach With Special Reference to the Study of Co-morbidity.
Bickel W, Mueller E
J Dual Diagn. 2010; 5(2):131-138.
PMID: 20182654
PMC: 2826844.
DOI: 10.1080/15504260902869147.